Cognitive and affective dysfunctions in autoimmune thyroiditis

Brain, Behavior, and Immunity

Volumn 41, Issue 1, 2014, Pages 261-266

  Leyhe, Thomas ^a   Müssig, Karsten ^b,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Affective disorders; Anti CNS antibodies; Anti TPO antibodies; Cognition; Hashimoto's encephalopathy; Hashimoto's thyroiditis; Psychosocial well being

Indexed keywords

CYTOKINE; GLUCOCORTICOID; LIOTRIX; NEUROTRANSMITTER; THYROID PEROXIDASE ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; IODIDE PEROXIDASE; THYROID MICROSOMAL ANTIBODIES;

ASTROCYTE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; BRAIN DISEASE; BRAIN FUNCTION; BRAIN PERFUSION; BRAIN REGION; CENTRAL NERVOUS SYSTEM; COGNITION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; EUTHYROIDISM; HASHIMOTO ENCEPHALOPATHY; HUMAN; IN VITRO STUDY; MONOCYTE; MOOD DISORDER; MYELIN SHEATH; MYELINATION; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; REVIEW; T LYMPHOCYTE; ANTIBODY SPECIFICITY; BIOSYNTHESIS; BRAIN; BRAIN DISEASES; CLASSIFICATION; COGNITION DISORDERS; COMPLICATION; HASHIMOTO DISEASE; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOOD DISORDERS; NEUROIMAGING; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

ADRENAL CORTEX HORMONES; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; BRAIN; BRAIN DISEASES; COGNITION DISORDERS; CYTOKINES; HASHIMOTO DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IODIDE PEROXIDASE; LYMPHOCYTE SUBSETS; MONOCYTES; MOOD DISORDERS; MYELIN SHEATH; NEUROIMAGING; PSYCHOLOGY; QUALITY OF LIFE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84924065159     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.03.008     Document Type: Review

References (68)

1. Baldini I.M., Vita A., Mauri M.C., Amodei V., Carrisi M., Bravin S., Cantalamessa L. Psychopathological and cognitive features in subclinical hypothyroidism. Prog. Neuropsychopharmacol. Biol. Psychiatry 1997, 21:925-935.
2. Bartalena L., Pellegrini L., Meschi M., Antonangeli L., Bogazzi F., Delĺ Osso L., Pinchera A., Placidi G.F. Evaluation of thyroid function in patients with rapid cycling and nonrapid-cycling bipolar disorder. Psychiatry Res. 1990, 34:13-17.
3. Bauer M., Goetz T., Glenn T., Whybrow P.C. The thyroid-brain interaction in thyroid disorders and mood disorders. J. Neuroendocrinol. 2008, 20:1101-1114.
4. Becker H., Hofmann M., Von Einsiedel H., Conrad B., Sander D. Umschriebene Vaskulitis mit Posteriorinfarkt bei Hashimoto-Encephalopathie. Nervenarzt 2002, 73:376-379.
5. Bianchi G.P., Zaccheroni V., Solaroli E., Vescini F., Cerutti R., Zoli M., Marchesini G. Health-related quality of life in patients with thyroid disorders. Qual. Life Res. 2004, 13:45-54.
6. Blanchin S., Coffin C., Viader F., Ruf J., Carayon P., Potier F., Portier E., Comby E., Allouche S., Ollivier Y., Reznik Y., Ballet J.J. Anti-thyroperoxidase antibodies from patients with Hashimoto's encephalopathy bind to cerebellar astrocytes. J. Neuroimmunol. 2007, 192:13-20.
7. Brain L., Jellinek E.H., Ball K. Hashimotós disease and encephalopathy. Lancet 1966, 2:512-514.
8. Bunevicius R., Peceliuniene J., Mickuviene N., Bunevicius A., Pop V.J., Girdler S.S. Mood and thyroid immunity assessed by ultrasonographic imaging in a primary health care. J. Affect. Disord. 2007, 97:85-90.
9. Carta M.G., Loviselli A., Hardoy M.C., Massa S., Cadeddu M., Sardu C., Carpiniello B., DelĺOsso L., Mariotti S. The link between thyroid autoimmunity (anti-thyroid peroxides autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 2004, 4:25.
10. Carta M.G., Hardoy M.C., Carpiniello B., Murru A., Marci A.R., Carbone F., Deiana L., Cadeddu M., Mariotti S. A case control study on psychiatric disorders in Hashimoto disease and euthyroid goitre: not only depressive but also anxiety disorders are associated with thyroid autoimmunity. Clin. Pract. Epidemiol. Ment. Health 2005, 1:23.
11. Catena-Dell'Osso M., Rotella F., Dell'Osso A., Fagiolini A., Marazziti D. Inflammation, serotonin and major depression. Curr. Drug Targets 2013, 14(5):571-577.
12. Chong J.Y., Rowland L.P., Utiger R.D. Hashimoto encephalopathy: syndrome or myth?. Arch. Neurol. 2003, 60:164-171.
13. Cummings R.R., Bagley S.C., Syed S., Dong N., Lin A. Hashimoto's encephalopathy: a case report with neuropsychological testing. Gen. Hosp. Psychiatry 2007, 29:267-269.
14. Davis J.D., Stern R.A., Flashman L.A. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Curr. Psychiatry Rep. 2003, 5:384-390.
15. Dorfman S.H., Fry J.M., Silberberg D.H. Antiserum induced myelination inhibition in vitro without complement. Brain Res. 1979, 177:105-114.
16. Eller T., Metsküla K., Talja I., Maron E., Uibo R., Vasar V. Thyroid autoimmunity and treatment response to escitalopram in major depression. Nord. J. Psychiatry 2010, 64:253-257.
17. Engum A., Bjøro T., Mykletun A., Dahl A.A. Thyroid autoimmunity, depression and anxiety: are there any connections? An epidemiological study of a large population. J. Psychosom. Res. 2005, 59:263-268.
18. Fatourechi V., McConahey W.M., Woolner L.B. Hyperthyroidism associated with histologic Hashimoto's thyroiditis. Mayo Clin. Proc. 1971, 46:682-689.
19. Ferracci F., Moretto G., Candeago R.M., Cimini N., Conte F., Gentile M., Papa N., Carnevale A. Antithyroid antibodies in the CSF: their role in the pathogenesis of Hashimoto's encephalopathy. Neurology 2003, 60:712-714.
20. Fountoulakis K.N., Iacovides A., Grammaticos P., Kaprinis G.S., Bech P. Thyroid function in clinical subtypes of major depression: an exploratory study. BMC Psychiatry 2004, 4:6.
21. Gini B., Laura L., Riccardo C., Laura C., Marconi S., Anghileri E., Alessandro A., Giuseppe M., Luca B., Franco F. Novel autoantigens recognized by CSF IgG from Hashimoto's encephalitis revealed by a proteomic approach. J. Neuroimmunol. 2008, 196:153-158.
22. Gold M.S., Pottash A.L.C., Extein I. "Symptomless" autoimmune thyroiditis in depression. Psychiatry Res. 1982, 6:261-269.
23. Goldman Consensus Group The Goldman consensus group statement on depression in multiple sclerosis. Mult. Scler. 2005, 11:328-337.
24. Guclu F., Ozmen B., Kirmaz C., Kafesciler S.O., Degirmenci P.B., Taneli F., Hekimsoy Z. Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with l-thyroxine. Eur. Cytokine Netw. 2009, 20:27-32.
25. Haggerty J.J., Silva S.G., Marquardt M., Mason G.A., Chang H.Y., Evans D.L., Golden R.N., Pedersen C. Prevalence of antithyroid antibodies in mood disorders. Depress. Anxiety 1997, 5:91-96.
26. Hardoy M.C., Cadeddu M., Serra A., Moro M.F., Mura G., Mellino G., Bhat K.M., Altoé G., Usai P., Piga M., Carta M.G. A pattern of cerebral perfusion anomalies between major depressive disorder and Hashimoto thyroiditis. BMC Psychiatry 2011, 11:148.
27. Hartmann M., Schaner B., Scheglmann K., Bücking A., Pfister R. Hashimoto-Enzephalopathie. Steroid-sensitive Enzephalopathie bei Hashimoto-Thyreoiditis. Nervenarzt 2000, 71:489-494.
28. Hillegers M.H., Reichart C.G., Wals M., Verhulst F.C., Ormel J., Nolen W.A., Drexhage H.A. Signs of a higher prevalence of autoimmune thyroiditis in female offspring of bipolar parents. Eur. Neuropsychopharmacol. 2007, 17:394-399.
29. Hirano T., Hashimoto H., Shiokawa Y., Iwamori M., Nagai Y., Kasai M., Ochiai Y., Okumura K. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J. Clin. Invest. 1980, 66:1437-1440.
30. Hornig M., Amsterdam J.D., Kamoun M., Goodman D.B. Autoantibody disturbances in affective disorders: a function of age and gender?. J. Affect. Disord. 1999, 55:29-37.
31. Irwin M.R., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain. Behav. Immun. 2007, 21:374-383.
32. Karanikas G., Schuetz M., Wahl K., Paul M., Kontur S., Pietschmann P., Kletter K., Dudczak R., Willheim R. Relation of anti-TPO autoantibody titre and T-lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin. Endocrinol. 2005, 63:191-196.
33. König F., von Hippel C., Petersdorf T., Kaschka W. Schilddrüsenautoantikörper bei depressiven Erkrankungen. Acta Med. Austrica 1999, 26:126-128.
34. Kokkotou E., Marafelia P., Mantzos E.I., Tritos N.A. Serum monocyte chemoattractant protein-1 is increased in chronic autoimmune thyroiditis. Metabolism 2002, 51:1489-1493.
35. Kothbauer-Margreiter I., Sturzenegger M., Komor J., Baumgartner R., Hess C.W. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J. Neurol. 1996, 243:585-593.
36. Kupka R.W., Nolen W.A., Post R.M., McElroy S.L., Altshuler L.L., Denicoff K.D., Frye M.A., Keck P.E., Leverich G.S., Rush A.J., Suppes T., Pollio C., Drexhage H.A. High rate of autoimmune thyroiditis in bipolar disorder. Lack of association with lithium exposure. Biol. Psychiatry 2002, 51:305-311.
37. Laske C., Leyhe T., Buchkremer G., Wormstall H. Depression bei Hashimoto- Enzephalopathie; Erfolgreiche Behandlung einer schweren depressiven Episode mit einem Kortikosteroid als Add-on-Therapie. Nervenarzt 2004, 5:617-622.
38. Lehmann H.C., Lopez P.H., Zhang G., Ngyuen T., Zhang J., Kieseier B.C., Mori S., Sheikh K.A. Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J. Neurosci. 2007, 27:27-34.
39. Leonard B.E. Changes in the immune system in depression and dementia: causal or co-incidental effects?. Int. J. Dev. Neurosci. 2001, 19:305-312.
40. Leyhe T., Morawetz C., Zank M., Buchkremer G., Eschweiler G.W. Epilepsy in an elderly patient caused by Hashimoto's encephalopathy. Epileptic Disord. 2007, 9:337-340.
41. Leyhe T., Müssig K., Weinert C., Laske C., Häring H.U., Saur R., Klingberg S., Gallwitz B. Increased occurrence of weaknesses in attention testing in patients with Hashimoto's thyroiditis compared to patients with other thyroid illnesses. Psychoneuroendocrinology 2008, 2008(33):1432-1436.
42. Leyhe T., Hügle M., Gallwitz B., Saur R., Eschweiler G.W. Increased occurrence of severe episodes in elderly depressed patients with elevated anti-thyroid antibody levels. Int. J. Geriatr. Psychiatry 2009, 24:779-781.
43. Leyhe T., Ethofer T., Bretscher J., Künle A., Säuberlich A.L., Klein R., Gallwitz B., Häring H.U., Fallgatter A., Klingberg S., Saur R., Müssig K. Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto's thyroiditis. Brain Behav. Immun. 2013, 27:33-37.
44. Miller A.H., Haroon E., Raison C.L., Felger J.C. Cytokine targets in the brain. Impact on neurotransmitter and neurocircuits. Depress. Anxiety 2013, 30:297-306.
45. Monzani F., Del Guerra P., Caraccio N., Pruneti C.A., Pucci E., Luisi M., Baschieri L. Subclinical hypothyroidism: neurobehavioral features and beneficial effect of l-thyroxine treatment. Clin. Invest. 1993, 71:367-371.
46. Müssig K., Bartels M., Gallwitz B., Leube D., Häring H.U., Kircher T. Hashimoto's encephalopathy presenting with bipolar affective disorder. Bipolar Disord. 2005, 7:1-6.
47. Müssig K., Leyhe T., Holzmüller S., Klein R., Weinert C., Saur R., Klingberg S., Häring H.U., Gallwitz B. Increased prevalence of antibodies to central nervous system tissue and gangliosides in Hashimot's thyroiditis compared to other thyroid illnesses. Psychoneuroendocrinology 2009, 34:1252-1256.
48. Müssig K., Künle A., Säuberlich A.L., Weinert C., Ethofer T., Saur R., Klein R., Häring H.U., Klingberg S., Gallwitz B., Leyhe T. Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis. Brain Behav. Immun. 2012, 26:559-563.
49. Nolte K.W., Unbehaun A., Sieker H., Kloss T.M., Paulus W. Hashimoto encephalopathy: a brainstem vasculitis?. Neurology 2000, 54:769-770.
50. Oide T., Tokuda T., Yazaki M., Watarai M., Mitsuhashi S., Kaneko K., Hashimoto T., Ohara S., Ikeda S. Anti-neuronal autoantibody in Hashimoto's encephalopathy: neuropathological, immunohistochemical, and biochemical analysis of two patients. J. Neurol. Sci. 2004, 217:7-12.
51. Oomen H.A.P.C., Schipperijn A.J.M., Drexhage H.A. The prevalence of affective disorder and in particular of a rapid cycling of bipolar disorder in patients with abnormal thyroid function tests. Clin. Endocrinol. 1996, 45:215-223.
52. Ott J., Promberger R., Kober F., Neuhold N., Tea M., Huber J.C., Hermann M. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011, 21:161-167.
53. Pearce E.N., Farwell A.P., Braverman L.E. Thyroiditis. N. Engl. J. Med. 2003, 348:2646-2655.
54. Piga M., Serra A., Deiana L., Loi G.L., Satta L., Di Liberto M., Mariotti S. Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur. J. Nucl. Med. Mol. Imaging 2004, 31:1639-1644.
55. Pollak Y., Orion E., Goshen I., Ovadia H., Yirmiya R. Experimental autoimmune encephalomyelitis-associated behavioural syndrome as a model of "depression due to multiple sclerosis". Brain Behav. Immun. 2000, 16:533-543.
56. Pop V.J., Maartens L.H., Leusink G., van Son M.J., Knottnerus A.A., Ward A.M., Metcalfe R., Weetman A.P. Are autoimmune thyroid dysfunction and depression related. J. Clin. Endocrinol. Metab. 1998, 83:3194-3197.
57. Prange A.J., Haggerty J.J., Browne J.L., Rice J.D. Marginal hypothyroidism in mental illness: preliminary assessments of prevalence and significance. Neuropsychopharmacology 1990, vol. 1:353-361. Springer Verlag, Berlin.
58. Schäuble B., Castillo P.R., Boeve B.F., Westmoreland B.F. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin. Neurophysiol. 2003, 114:32-37.
59. Seidel A., Arolt V., Hunstiger M., Rink L., Behnisch A., Kirchner H. Increased CD56+ natural killer cells and related cytokines in major depression. Clin. Immunopathol. 1996, 78:83-85.
60. Sluzewska A., Rybakowski L., Bosmans E., Sobieska M., Berghmans R., Maes M., Wiktorowicz K. Indicators of immune activation in major depression. Psychiatry Res. 1996, 64:161-167.
61. Vanderpump M.P., Tunbridge W.M. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002, 12:839-847.
62. Vonk R., van der Schot A.C., Kahn R.S., Nolen W.A., Drexhage H.A. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder?. Biol. Psychiatry 2007, 62:135-140.
63. Weiner S.M., Klein R., Berg P.A.A. Longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases. Rheumatol. Int. 2000, 19:83-88.
64. Whybrow P.C., Prange A.J., Treadway C.R. Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement. Arch. Gen. Psychiatry 1969, 20:48-63.
65. Zandman-Goddard G., Chapman J., Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 2007, 36:297-315.
66. Zephir H., De Seze J., Stoikovic T., Delisse B., Ferriby D., Cabaret M., Vermersch P. Multiple sclerosis and depression: influence of interferon beta therapy. Mult. Scler. 2003, 9:284-288.
67. Zettinig G., Asenbaum S., Fueger B.J., Hofmann A., Hofman A., Diemling M., Mittlboeck M., Dudczak R. Increased prevalence of subclinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis?. Clin. Endocrinol. (Oxf.) 2003, 59:637-643.
68. Zorilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain. Behav. Immun. 2001, 15:199-226.